David E. Martin

TrippBio, Inc. engages in biotechnology industry. The company is headquartered in Jacksonville, FL.

Panacos Pharmaceuticals is engaged in the discovery and development of small molecule oral drugs for the treatment of HIV and other major human viral diseases. Panacos’ proprietary discovery technologies focus on novel targets in the virus life cycle, including virus fusion and virus maturation, the first and last steps of viral infection

Part of Charles River Laboratories International, Inc., PharmaResearch Corp is a company that provides pharmaceutical development and research services. The company is based in Wilmington, NC. The company was founded by James Douglas Esinhart. PharmaResearch was acquired by Inveresk Research Group, Inc., part of Charles River Laboratories International, Inc. from October 20, 2004 on July 29, 2003 for $37.10 million.

Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA.